VOL. 2 NO. 10
CANCER INSIGHT
THE
At right, the photomicrograph shows
the chronic phase of chronic myeloid
leukemia. The inset photomicrographs
show the leukemia blast cells for a case
of acute promyelocytic leukemia.
UNIVERSITY
OF
ALABAMA
AT
BIRMINGHAM
Oncology Advancing at UAB
The recruitment of national leaders for UAB programs
Publications of Note
UAB Medicine News
3
3
a new inpatient consult service, which facilitates
is helping keep UAB among the nation’s top cancer
screening all new leukemia patients for BMT eligibility
treatment and research centers. Boris Pasche, MD, PhD,
2
transplantation. Since arriving at UAB he has established
urologic oncology, and thoracic oncology programs
New Physicians
transplantation, and HLA-mismatch stem cell
in bone marrow transplant, hematologic malignancy,
and helps in early identification of donors. Over the past
director of the Division of Hematology and Oncology,
4 months the numbers of allogeneic BMT procedures
provided details:
have doubled.
Bone Marrow Transplant. Shin Mineishi, MD, PhD,
Mineishi leads a staff of six, including Ayman Saad,
3
Noteworthy Presentations
4
MD, previously of the University of Wisconsin. They
Vaughan, MD, who has stepped down after a 20-year
Featured Clinical Trial
recently was recruited as director to succeed William
are supported by a 16-bed inpatient BMT unit, an
tenure, during which BMT became a premier program.
attached 9-bed outpatient BMT unit, and a new Stem Cell
Mineishi, formerly of the University of Michigan,
is a pioneer in pretransplant conditioning regimens,
Laboratory, the only one accredited in Alabama.
“BMT is poised for significant growth,” says Pasche.
graft versus host disease, complications after stem
“We have the infrastructure to expand our applications
cell transplantation, reduced intensity stem cell
beyond leukemia, lymphoma, and multiple myeloma
continued on page 2